OP
REGN icon

ORG Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

ORG Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$53.2K Buy
69
+31
+82% +$21.1K 0.01% 570
2025
Q3 		$21.4K Sell
38
-2
-5% -$1.13K ﹤0.01% 786
2025
Q2 		$21.4K Buy
40
+27
+208% +$15.1K ﹤0.01% 737
2025
Q1 		$8.02K Buy
+13
New +$8.94K ﹤0.01% 843

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ORG Partners's REGN Position: Q4 2025 in Review

ORG Partners increased its Regeneron Pharmaceuticals (REGN) stake by 82% in Q4 2025, buying an estimated $21.1K and bringing the position to 69 shares worth $53.2K. The position accounts for 0.01% of the portfolio, ranked #570.

ORG Partners first reported a position in REGN in Q1 2025 and has held it in 4 quarters since. 1,385 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • ORG Partners held 69 shares of Regeneron Pharmaceuticals worth $53.2K as of Q4 2025.
  • ORG Partners bought 31 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $21.1K.
  • Regeneron Pharmaceuticals made up 0.01% of ORG Partners's portfolio in Q4 2025, its #570 holding.
  • ORG Partners first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 1,385 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.